MedPath

Introducing early Palliative care in Lymphoma

Not Applicable
Registration Number
CTRI/2022/10/046652
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Adult patients of age >= 18 years

2)Adult patients with HG relapsed/refractory NHL expected to receive salvage chemotherapy attending the Adult Haemato-oncology lymphoma Joint clinic at Tata Memorial hospital.

3) Elderly patients >= 60years newly diagnosed with HG NHL expected to receive appropriate Chemotherapy/radiotherapy attending the Adult Haemato-oncology lymphoma Joint clinic at Tata Memorial hospital.

4)Patient has been informed of the diagnosis, treatment and prognosis of the disease.

5)Able to communicate in English/Marathi/Hindi/Bengali

6)Performance score of <4 on the Eastern Cooperative Oncology group scale (ECOG)

7)Able to give a written informed consent

Exclusion Criteria

1)Patients who are planned for best supportive care alone

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath